logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong Stock Market Anomaly | Weichai Power (02338.HK) drops more than 7% in early trading. The company has reached a cooperation agreement with Ceres Power. The announcement states that the agreement does not meet disclosure standards.

date
07/11/2025
According to the financial news app Zhitong, Weichai Power (02338.HK) fell over 7% in the morning session, dropping 6.7% to HK$20.06 at the time of writing, with a turnover of HK$2.04 billion.
Latest
2 m ago
Langfang Holdings Group has established a Low Altitude Industry Development Company with a registered capital of 10 million RMB.
3 m ago
Yuan Rong embarked on a capital increase to 2.5 billion yuan, an increase of approximately 1276061%.
4 m ago
Seven multinational pharmaceutical companies at the Import Expo reached a strategic cooperation with Meituan Health.
5 m ago
Meituan Medical Health made its first appearance at the China International Import Expo and within two days reached strategic cooperation agreements with seven multinational pharmaceutical and health companies such as AstraZeneca, Bayer, Oculon, Pfizer, LEO Pharma, Gilead Sciences, and Durex, becoming an important partner in expanding their market in China. (Xinhua Finance)
6 m ago
JD CEO Liu Qiangdong: Employee future working hours may be reduced, express delivery does not require human involvement.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.